Rika Regentin

3.6k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Rika Regentin is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Rika Regentin has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Rika Regentin's work include Microbial Natural Products and Biosynthesis (11 papers), Plant biochemistry and biosynthesis (7 papers) and Cancer Treatment and Pharmacology (4 papers). Rika Regentin is often cited by papers focused on Microbial Natural Products and Biosynthesis (11 papers), Plant biochemistry and biosynthesis (7 papers) and Cancer Treatment and Pharmacology (4 papers). Rika Regentin collaborates with scholars based in United States and South Korea. Rika Regentin's co-authors include Hiroko Tsuruta, Neil S. Renninger, Jack D. Newman, Jay D. Keasling, Christopher J. Paddon, Diana G. Eng, Tizita Horning, Frank X. Woolard, Michael D. Leavell and Patrick J. Westfall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Applied Microbiology and Biotechnology.

In The Last Decade

Rika Regentin

16 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin

2012 551 citations Patrick J. Westfall, Douglas J. Pitera et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rika Regentin United States	12	1.1k	495	152	129	92	16	1.2k
Hiroko Tsuruta United States	8	920 0.9×	373 0.8×	132 0.9×	127 1.0×	89 1.0×	11	1.0k
Claudia Schmidt-Dannert United States	15	1.1k 1.0×	197 0.4×	179 1.2×	170 1.3×	155 1.7×	19	1.3k
Ngoc B. Pham Australia	13	327 0.3×	185 0.4×	121 0.8×	34 0.3×	52 0.6×	22	696
Bert van Loo United Kingdom	14	652 0.6×	89 0.2×	90 0.6×	92 0.7×	161 1.8×	21	806
Joseph A. Chemler United States	17	1.1k 1.0×	662 1.3×	266 1.8×	121 0.9×	38 0.4×	21	1.4k
Frank VanMiddlesworth United States	17	812 0.8×	289 0.6×	170 1.1×	60 0.5×	64 0.7×	24	1.4k
Xinkai Xie United States	15	716 0.7×	718 1.5×	270 1.8×	48 0.4×	23 0.3×	16	1.0k
Peggy J. Brodie United States	20	526 0.5×	207 0.4×	135 0.9×	33 0.3×	74 0.8×	54	977
Steven G. Kendrew United Kingdom	15	809 0.8×	932 1.9×	338 2.2×	38 0.3×	69 0.8×	23	1.4k
Elena Fossati Canada	10	340 0.3×	210 0.4×	35 0.2×	37 0.3×	90 1.0×	13	504

Countries citing papers authored by Rika Regentin

Since Specialization

Citations

This map shows the geographic impact of Rika Regentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Regentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Regentin more than expected).

Fields of papers citing papers by Rika Regentin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Regentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Regentin. The network helps show where Rika Regentin may publish in the future.

Co-authorship network of co-authors of Rika Regentin

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Regentin. A scholar is included among the top collaborators of Rika Regentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Regentin. Rika Regentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Westfall, Patrick J., Douglas J. Pitera, Diana G. Eng, et al.. (2012). Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proceedings of the National Academy of Sciences. 109(3). 551 indexed citations breakdown →

Tsuruta, Hiroko, Christopher J. Paddon, Diana G. Eng, et al.. (2009). High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli. PLoS ONE. 4(2). e4489–e4489. 278 indexed citations

Tsuruta, Hiroko, et al.. (2008). Developing an industrial artemisinic acid fermentation process to support the cost‐effective production of antimalarial artemisinin‐based combination therapies. Biotechnology Progress. 24(5). 1026–1032. 67 indexed citations

Patel, Kedar G., Zong‐Qiang Tian, Greg O. Buchanan, et al.. (2006). Engineered Biosynthesis of Geldanamycin Analogs for Hsp90 Inhibition. Chemistry & Biology. 13(3). 341–341. 3 indexed citations

Buchanan, Greg O., et al.. (2005). Production of 8-Demethylgeldanamycin and 4,5-Epoxy-8-demethylgeldanamycin from a Recombinant Strain of Streptomyces hygroscopicus. Journal of Natural Products. 68(4). 607–610. 19 indexed citations

Patel, Kedar G., Zong‐Qiang Tian, Greg O. Buchanan, et al.. (2004). Engineered Biosynthesis of Geldanamycin Analogs for Hsp90 Inhibition. Chemistry & Biology. 11(12). 1625–1633. 107 indexed citations

Hu, Zhihao, Yaoquan Liu, Zong‐Qiang Tian, et al.. (2004). Isolation and Characterization of Novel Geldanamycin Analogues. The Journal of Antibiotics. 57(7). 421–428. 20 indexed citations

Regentin, Rika, Jonathan Kennedy, Nicholas Wu, et al.. (2004). Precursor-Directed Biosynthesis of Novel Triketide Lactones. Biotechnology Progress. 20(1). 122–127. 17 indexed citations

Hu, Zhihao, Yaoquan Liu, Zong‐Qiang Tian, et al.. (2004). Isolation and Characterization of Novel Geldanamycin Analogues.. ChemInform. 36(1). 1 indexed citations

10.

Regentin, Rika, et al.. (2003). Nutrient regulation of epothilone biosynthesis in heterologous and native production strains. Applied Microbiology and Biotechnology. 61(5-6). 451–455. 11 indexed citations

11.

Lau, Janice, et al.. (2002). Optimizing the heterologous production of epothilone D in Myxococcus xanthus. Biotechnology and Bioengineering. 78(3). 280–288. 59 indexed citations

12.

Regentin, Rika, et al.. (2002). Production of a novel FK520 analog in Streptomyces hygroscopicus: Improving titer while minimizing impurities. Journal of Industrial Microbiology & Biotechnology. 28(1). 12–16. 11 indexed citations

13.

Tsuruta, Hiroko, Janice Lau, Rika Regentin, et al.. (2002). Modulation of epothilone analog production through media design. Journal of Industrial Microbiology & Biotechnology. 28(1). 17–20. 11 indexed citations

14.

Tsuruta, Hiroko, et al.. (2002). Control of Secondary Metabolite Congener Distributions via Modulation of the Dissolved Oxygen Tension. Biotechnology Progress. 18(5). 913–920. 7 indexed citations

15.

Leaf, Timothy, Mark A. Burlingame, Ruchir P. Desai, et al.. (2002). Employing racemic precursors in directed biosynthesis of 6‐dEB analogs. Journal of Chemical Technology & Biotechnology. 77(10). 1122–1126. 9 indexed citations

16.

Leaf, Timothy, et al.. (2000). Precursor‐Directed Biosynthesis of 6‐Deoxyerythronolide B Analogs in Streptomycescoelicolor: Understanding Precursor Effects. Biotechnology Progress. 16(4). 553–556. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact